Directors & dealings data is unavailable for this security.
Directors & Officers
Click or tap a row for biographies
Name | Title | Compensation | Age | Officer since |
---|---|---|---|---|
Randal Kirk | Executive Chairman of the Board | 100.00kUSD | 70 | 2008 |
Helen Sabzevari | President, Chief Executive Officer, Director, President of PGEN Therapeutics, Inc. | 1.00mUSD | 62 | 2017 |
Harry Thomasian | Chief Financial Officer | 475.00kUSD | 62 | 2021 |
Rutul Shah | Chief Operating Officer | 410.00kUSD | 43 | 2022 |
Phil Tennant | Chief Commercial Officer | -- | -- | 2024 |
Director dealings
Dealing date | Name / Title | Deal size (USD) |
---|